EU announces deal for up to 300 million doses of Pfizer / BioNTech COVID-19 vaccine
The EU has reached an agreement with Pfizer and BioNTech for their COVID-19 vaccine, which reported 90% efficacy earlier this week.
Archives for November 10, 2020
Adverse event in COVID-19 vaccine trial ‘not related to vaccine’, says Sinovac
Sinovac’s Phase 3 COVID-19 vaccine trial has been put on hold in Brazil after a serious adverse event. But in a statement this morning, the company says the event is not related to the vaccine.
Novavax’s COVID-19 vaccine gets Fast Track Designation from the FDA
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for Novavax’s COVID-19 vaccine. Novavax plans to start Phase 3 trials for the candidate in the US and Mexico by the end of the month.
Lilly’s monoclonal antibody is the first to be authorized for use in treating COVID-19
Lilly's monoclonal antibody therapy, bamlanivimab (LY-CoV555), has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for the treatment of adults and children with recently diagnosed, mild to moderate COVID-19.
Biogen ‘continues to work’ with FDA on Alzheimer's drug candidate despite regulatory setback
Biogen Inc’s shares tumbled around 30% yesterday with the company hitting a roadblock late last week as it chases regulatory approval for its investigational Alzheimer's treatment.